FIELD: medicine, narcology. SUBSTANCE: one should introduce naloxon parenterally at the dosage of 0.4-0.8 mg/intake in 0.25-4.0 h till the onset of medicinal dream at further introduction of the above-mentioned preparation after awakening till regress of clinical symptomatics. The present innovation enables to simultaneously reduce several clinical symptoms in more shortened time intervals. EFFECT: higher efficiency. 1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF STOPPING ALCOHOL ABSTINENCE | 2010 |
|
RU2428984C1 |
METHOD OF ALCOHOLIC ABSTINENCE SYNDROME REDUCTION | 2006 |
|
RU2327474C1 |
METHOD OF RELIEVING ALCOHOL ABSTINENCE SYNDROME BY BLOCKADE OF BENZODIAZEPINE RECEPTORS | 2011 |
|
RU2468799C1 |
METHOD FOR PROPHYLAXIS OF RELAPSES IN CASE OF ALCOHOLISM | 2002 |
|
RU2236230C2 |
METHOD FOR ARRESTING ALCOHOL WITHDRAWAL SYNDROME | 1987 |
|
RU2022556C1 |
METHOD OF TREATMENT OF WITHDRAWAL SYNDROME WITH ALCOHOLISM AND DRUG ADDICTION | 2017 |
|
RU2648359C1 |
METHOD OF ABSTINENCE SYNDROME TREATMENT | 2010 |
|
RU2422139C1 |
METHOD FOR ALLEVIATING COMPLICATED ABSTINENCE SYNDROME | 1992 |
|
RU2067442C1 |
METHOD OF REHABILITATION OF PATIENTS WITH ALCOHOLISM | 2009 |
|
RU2436573C2 |
METHOD OF TREATMENT IN ALCOHOLIC DELIRIUM | 2005 |
|
RU2300376C2 |
Authors
Dates
2003-11-10—Published
2001-09-28—Filed